BON Bon Natural Life Ltd

BON financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1816815 Exchange: Nasdaq SIC: 2833 (Medicinal Chemicals & Botanical Products) Latest filing: 20-F filed Jan 23, 2026 Data checked: Oct 21, 2026
Showing 3 of 7 annual and 0 of 0 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Emerging growth company
Entity Type
Other
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Incorporated
E9
Fiscal Year End
September (0930)
Phone
0086-29-88346301
EIN
000000000
Headquarters
SHAANXI, F4, 710076

▼ Key Metrics (FY 2025)

As of Sep 30, 2025
Financials
Revenue
$18.67M
Net Income
$-1.99M
Total Assets
$85.19M
Total Equity
$58.00M
Total Debt
$1.92M
Free Cash Flow
$134.29K
Ratios
Gross Margin
20.8%
Operating Margin
-8.7%
Net Margin
-10.7%
Return on Equity
-3.4%
Return on Assets
-2.3%
Current Ratio
1.74x
Debt / Equity
0.03x
FCF / Assets
0.2%
Revenue Growth (YoY)
-21.7%
EPS Growth (YoY)
-117.4%

▼ FY 2025 Summary Analysis

Annual report ending Sep 30, 2025

Overview and Growth

Fiscal 2025 results for Bon Natural Life Ltd combined $18.67M of revenue with net loss of $1.99M and an operating cash inflow of $141.12K. The $18.67M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. The top line contracted 21.7% from $23.84M in fiscal 2024; this top-line contraction left the company with a smaller revenue base. On a per-share basis, diluted EPS was -$0.72, which connects the reported earnings outcome with the company’s diluted share count. Diluted EPS decreased by 117.4% from $4.14 in fiscal 2024, showing how the earnings change reached shareholders on a per-share basis. Asset turnover was 0.22x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

After reported cost of revenue, the company retained $3.88M as gross profit before recognizing operating expenses and other items. Gross margin was 20.8%, so that share of each revenue unit remained after the cost of revenue reported for the period. The reported operating result was an operating loss of $1.62M, reflecting costs that exceeded gross profit. The operating loss equaled 8.7% of revenue, showing the scale of the operating deficit relative to sales. The company ended the period with a net loss of $1.99M, extending the operating result through all remaining items. Measured against revenue, the bottom-line deficit represented 10.7% after all recognized items. Before income taxes, the company recorded a loss of $1.71M, bridging the operating result to the final net loss. Pretax margin was -9.2%, reflecting a pre-tax loss equal to 9.2% of revenue. The reported income-tax provision was $339.41K, the amount recognized between pretax income and the final net-income result. The loss-to-equity relationship was 3.4%, placing the bottom-line deficit against shareholder capital. Relative to total assets, the net loss represented 2.3%.

Liquidity and Capital Structure

Total assets were $85.19M, supported by $27.19M of liabilities and $58.00M of shareholder equity. At period end, current assets of $45.76M compared with current liabilities of $26.31M, defining the company’s short-term resource position. At 1.74x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $6.27M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 23.8% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. The company carried $1.92M of total debt at period end, which frames its leverage and debt-service burden. Against book equity, debt measured 0.03x, placing the company’s financial leverage in clear balance-sheet terms. Relative to total assets, debt measured 2.3%, showing how much of the asset base was matched by borrowing. The liabilities-to-assets relationship was 31.9%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 7.4%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $61.77M in fiscal 2024, the current asset base moved 37.9% and finished higher.

Cash Flow and Earnings Quality

The company reported $141.12K of operating cash flow, a cash inflow that shows the cash generated by operations. Capital spending was $6.83K, absorbing part of the cash generated from operations before free cash flow. Capital spending absorbed 4.8% of operating cash flow, quantifying the share of cash from operations directed to investment. Free cash flow came to $134.29K, leaving a positive amount after capital expenditures. Relative to revenue, free cash flow equaled 0.7%, showing how much sales converted into cash after investment. Free cash flow equaled 0.2% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Sep 30, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Bon Natural Life Ltd
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $18.67M $23.84M $29.52M
Cost of Revenue $14.79M $16.73M $20.68M
Gross Profit $3.88M $7.11M $8.84M
OPERATING EXPENSES
R&D Expense $754.19K $1.62M $298.47K
SG&A Expense $4.31M $3.35M $2.31M
Other Operating Expenses (derived) $436.93K $270.58K $293.72K
Operating Income $-1.62M $1.87M $5.94M
NON-OPERATING INCOME / EXPENSE
Interest Expense $366.18K $303.33K $238.22K
Interest Income $867 $393 $9.41K
Other Income/Expense $80.33K $-918.18K $-160.26K
Pretax Income $-1.71M $715.94K $5.57M
Income Tax $339.41K $351.18K $1.00M
Net Income $-1.99M $398.17K $4.60M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-0.72 $4.14 $124.92
Diluted Shares 2.76M 96.11K 36.79K
EBITDA $-535.58K $2.98M $6.89M
Depreciation & Amortization $1.09M $1.11M $949.55K
Balance Sheet
ASSETS
Cash & Equivalents $6.27M $80.47K $112.75K
Short-term Investments - - $65
Accounts Receivable $11.01M $11.78M $4.60M
Inventory $3.31M $1.57M $987.29K
Other Current Assets $8.71M $4.30M $2.36M
Current Assets $45.76M $39.79M $24.18M
PP&E (Net) $18.16M $15.01M $15.48M
Intangible Assets $6.42M $777.00K $766.35K
Noncurrent Assets $39.43M $21.97M $22.37M
Total Assets $85.19M $61.77M $46.56M
LIABILITIES
Accounts Payable $7.64M $3.43M $1.40M
Short-term Debt $1.08M $461.77K $419.61K
Other Current Liabilities $134.07K $244.87K $77.21K
Current Liabilities $26.31M $16.45M $9.61M
Long-term Debt $842.82K $970.06K $871.37K
Other Noncurrent Liabilities (derived) $36.60K $0 $91.72K
Noncurrent Liabilities $879.42K $970.06K $963.09K
Total Liabilities $27.19M $17.42M $10.57M
EQUITY
Common Stock - $3.97K $1.17K
Additional Paid-in Capital $40.79M $25.01M $18.09M
Retained Earnings $16.63M $18.74M $18.70M
Accumulated OCI $-2.88M $-2.58M $-3.68M
Total Equity $58.00M $44.35M $35.98M
Total Liabilities & Equity $85.19M $61.77M $46.56M
SUPPLEMENTAL
Total Debt $1.92M $1.43M $1.29M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $141.12K $-7.72M $-616.90K
Capital Expenditures $6.83K $7.05K $61.91K
Cash from Investing $-10.00M $-15.73K $-1.19M
Cash from Financing $15.45M $8.76M $1.16M
Free Cash Flow $134.29K $-7.73M $-678.81K
Beginning Cash (CFS) $658.61K $112.75K $840.86K
Net Change in Cash $5.60M $1.02M $-647.32K
Effect of FX on Cash $7.39K $-469.82K $-80.79K
Calculated Ending Cash $6.27M $658.61K $112.75K
Cash per BS $6.27M $80.47K $112.75K
Cash scope difference (CFS − BS) - $578.14K -
Cash per CFS $6.27M $658.61K $112.75K

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Bon Natural Life Ltd's annual revenue?

Bon Natural Life Ltd reported $18.67M in revenue for fiscal year 2025 (ending September 2025). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Bon Natural Life Ltd profitable?

No. Bon Natural Life Ltd reported $-1.99M in net income for fiscal year 2025. Profitability data is based on the company's most recent annual report filed with the SEC.

What is Bon Natural Life Ltd's debt level?

Bon Natural Life Ltd carries $1.92M in total debt as of fiscal year 2025. Total shareholders' equity stands at $58.00M.

Does Bon Natural Life Ltd generate free cash flow?

Yes. Free cash flow was $134.29K for fiscal year 2025. Operating cash flow was $141.12K.